Does atrial fibrillation in very elderly patients with chronic systolic heart failure limit the use of carvedilol?

International Journal of Cardiology

Volumn 107, Issue 2, 2006, Pages 220-224

  Cioffi, Giovanni ^a   De Feo, Stefania ^b   Pulignano, Giovanni ^c   Del Sindaco, Donatella ^d   Tarantini, Luigi ^e   Stefenelli, Carlo ^a   Opasich, Cristina ^b  

^a Villa Bianca Hospital   (Italy)

^b IRCCS   (Italy)

^c SAN CAMILLO FORLANINI HOSPITAL   (Italy)

^d INRCA   (Italy)

^e SAN MARTINO HOSPITAL   (Italy)

Author keywords

Atrial fibrillation; Carvedilol; Elderly; Heart failure

Indexed keywords

ANGIOTENSIN 1 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; SPIRONOLACTONE;

ADULT; AGED; ARTICLE; BRADYCARDIA; BRONCHOSPASM; CONTROLLED STUDY; DEPRESSION; DISEASE EXACERBATION; DOSE CALCULATION; DRUG CONTRAINDICATION; DRUG DOSE REDUCTION; DRUG SAFETY; DRUG TOLERABILITY; DRUG USE; DRUG WITHDRAWAL; FEASIBILITY STUDY; FEMALE; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE ARRHYTHMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MAXIMUM TOLERATED DOSE; MITRAL VALVE REGURGITATION; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESPIRATORY TRACT DISEASE; SINUS RHYTHM; SYSTOLIC BLOOD PRESSURE;

ADRENERGIC BETA-ANTAGONISTS; AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; CARBAZOLES; CHRONIC DISEASE; ELIGIBILITY DETERMINATION; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; HEART CONDUCTION SYSTEM; HEART FAILURE, CONGESTIVE; HUMANS; MALE; PATIENT READMISSION; PROPANOLAMINES; PROSPECTIVE STUDIES; STROKE VOLUME; SYSTOLE; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 30444459051     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2005.03.028     Document Type: Article

References (32)

1. J.M. Foody, M.H. Farrel, and H.M. Krumholz Beta-blocker therapy in heart failure JAMA 287 2002 833 889
2. Effect of metoprolol CR/XL in chronic heart failure: metoprolol CR/XL randomized intervention trial in congestive heart failure (MERIT-HF) Lancet 353 1999 2001 2007
3. Cardiac Insufficiency Bisoprolol Study II (CIBIS II): a randomized trial Lancet 353 1999 9 13
4. M. Packer, M.R. Bristow, J.N. Cohn, W.S. Colucci, M.B. Fowler, and E.M. Gilbert The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. US Carvedilol Heart Failure Study Group N Engl J Med 334 1996 1349 1355
5. D.D. Sin, and F.A. McAlister The effects of beta-blockers on morbidity and mortality in a population-based cohort of 11942 elderly patients with heart failure Am J Med 113 2002 650 656
6. M.C. Shibata, M.D. Flather, M. Bohm, J. Borbola, A. Cohen-Solal, and D. Dumitrascu Study of the effects of Nebivolol Intervention on Outcomes and Rehospitalisation in Seniors with heart failure (SENIORS). Rationale and design Int J Cardiol 86 2002 77 85
7. P.E. Carson, G.R. Johnson, W.B. Dunkman, R.D. Fletcher, L. Farrell, and J.N. Cohn The influence of atrial fibrillation on prognosis in mild to moderate heart failure Circulation 87 1993 VI102 VI110
8. H.C. Doval, D.R. Nul, H.O. Grancelli, S.V. Perrone, G.R. Bortman, and R. Curiel Randomized trial of low-dose amiodarone in severe congestive heart failure Lancet 334 1994 493 498
9. S.N. Singh, R.D. Fletcher, S.G. Fisher, B.N. Singh, H.D. Lewis, and P.C. Deedwania Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia N Engl J Med 333 1995 77 82
10. J.N. Cohn, D.G. Archibald, S. Ziesche, J.A. Franciosa, W.E. Harston, and F.E. Tristani Effect of vasodilator therapy on mortality in chronic congestive heart failure. Result of a Veterans Administration Cooperative Study (V-HeFT) N Engl J Med 314 1986 1542 1547
11. J.N. Cohn, G. Johnson, S. Ziesche, F. Cobb, G. Francis, and F. Tristani A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure N Engl J Med 314 1991 1547 1552
12. C. Torp-Pedersen, M. Moller, P.E. Bloch-Thomsen, L. Kober, E. Sandoe, and K. Egstrup Dofetilide in patients with congestive heart failure and left ventricular dysfunction N Engl J Med 341 1999 857 965
13. H.R. Middlekauff, W.G. Stevenson, and L.W. Stevenson Prognostic significance of atrial fibrillation in advanced heart failure Circulation 84 1991 40 48
14. P.A. Wolf, J.B. Mitchell, C.S. Baker, W.B. Kannel, and R.B. D'Agostino Impact of atrial fibrillation on mortality, stroke, and medical costs Arch Intern Med 158 1998 229 234
15. E.J. Benjamin, P.A. Wolf, R.B. D'Agostino, H. Silbershatz, W.B. Kannel, and D. Levy Impact of atrial fibrillation on the risk of death: the Framingham heart study Circulation 98 1998 946 952
16. D.L. Dries, D.V. Exner, B.J. Gersh, M.J. Domanski, M.A. Waclawiw, and L.W. Stevenson Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials J Am Coll Cardiol 32 1998 695 703
17. M. Pozzoli, G. Cioffi, E. Traversi, G.D. Pinna, F. Cobelli, and L. Tavazzi Predictors of primary atrial fibrillation and concomitant clinical and hemodynamic changes in patients with chronic heart failure: a prospective study in 344 patients with baseline sinus rhythm J Am Coll Cardiol 32 1998 197 204
18. J.A. Joglar, A.P. Acusta, N.H. Shusterman, K. Ramaswamy, R.C. Kowal, and S.J. Barbera Effect of carvedilol on survival and hemodynamics in patients with atrial fibrillation and left ventricular dysfunction: retrospective analysis of the US carvedilol heart failure trials program Am Heart J 142 2001 498 501
19. J.W.H. Fung, S.K.W. Chan, L.Y.C. Yeung, and J.E. Sanderson Is beta-blockage useful in heart failure patients with atrial fibrillation? An analysis of data from two previously completed prospective trials Eur J Heart Fail 4 2002 489 494
20. R.H. Arnold, E. Kotlyar, C. Hayward, A.M. Keogh, and P.S. Macdonald Relation between heart rate, heart rhythm, and reverse left ventricular remodelling in response to carvedilol in patients with chronic heart failure: a single centre, observational study Heart 89 2003 293 298
21. K.A. Schleman, J.A. Lindenfeld, B.D. Lowes, M.R. Bristow, D. Ferguson, and E.E. Wolfel Predicting response to carvedilol for the treatment of heart failure: a multivariate retrospective analysis J Card Fail 7 2001 4 12
22. P. Lechat, J.S. Hulot, S. Escolano, A. Mallet, A. Leizorovicz, and M. Werhlen-Grandjean Heart rate and cardiac rhythm relationships with bisoprolol benefit in chronic heart failure in CIBIS II trial Circulation 103 2001 1428 1433
23. H. Wedel, D. Demets, P. Deedwania, B. Fagerberg, S. Goldstein, and S. Gottlieb Challenges of subgroup analyses in multinational clinical trials: experiences from the MERIT-HF trial Am Heart J 142 2001 502 511
24. E. Kotlyar, A.M. Keogh, P.S. Macdonald, R.H. Arnold, D.J. McCaffrey, and A.R. Glanville Tolerability of carvedilol in patients with heart failure and concomitant chronic obstructive pulmonary disease or asthma J Heart Lung Transplant 21 2002 1290 1295
25. Cochrane Airways Group registry Cardioselective beta-blockers for reversible airways disease Cochrane Database Syst Rev 1 2002 [CD 002992]
26. H. Krum, D. Ninio, and P. MacDonald Baseline predictors of tolerability to carvedilol in patients with chronic heart failure Heart 84 2000 615 619
27. A.J. Baxter, A. Spensley, A. Hildreth, G. Karimova, J.E. O'Connel, and C.S. Gray Beta-blockers in older persons with heart failure: tolerability and impact on quality of life Heart 88 2002 611 614
28. H. Krum, E.B. Roecker, P. Mohacsi, J.L. Rouleau, M. Tendera, and A.J. Coats Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) study. Effects of initiating carvedilol in patients with severe chronic heart failure results from the Copernicus study JAMA 289 2003 754 756
29. A.P. Maggioni, G. Sinagra, C. Opasich, E. Geraci, M. Gorini, and E. Gronda Beta blockers in patients with congestive heart failure: guided use in clinical practice investigators. Treatment of chronic heart failure with beta adrenergic blockade beyond controlled clinical trials: the bring-up experience Heart 89 2003 299 305
30. P.S. Macdonald, A.M. Keogh, C.L. Aboyoun, M. Lund, R. Amor, and D.J. McCaffrey Tolerability and efficacy of carvedilol in patients with New York heart association class IV heart failure J Am Coll Cardiol 33 1999 924 931
31. P.A. Rochon, J.V. Tu, G.M. Anderson, J.H. Gurwitz, J.P. Clark, and P. Lau Rate of heart failure and 1-year survival for older people receiving low-dose beta-blocker therapy after myocardial infarction Lancet 356 2000 639 644
32. Prevalence, predictors and prognostic implications of improvement in left ventricular systolic function and clinical status in patients > 70 years of age with recently diagnosed systolic heart failure G. Cioffi C. Stefenelli L. Tarantini C. Opasich Am. J. Cardiol. vol. 92 2003 166 172